Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of


GlobeNewswire Inc | Oct 21, 2020 04:17PM EDT

October 21, 2020

WILMINGTON, Del., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

Concho Resources Inc. (NYSE CXO) regarding possible breaches of fiduciary duties and other violations of law related to Concho Resources agreement to be acquired by ConocoPhillips. Under the terms of the agreement Concho Resources shareholders will receive 1.46 shares of ConocoPhillips common stock per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-concho-resources-inc.

BioSpecifics Technologies Corp. (NASDAQ GM: BSTC) regarding possible breaches of fiduciary duties and other violations of law related to BioSpecifics Technologies agreement to be acquired by Endo International plc. Under the terms of the agreement, BioSpecifics Technologies shareholders will receive $88.50 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-biospecifics-technologies-corp.

MyoKardia, Inc. (NASDAQ GS: MYOK) regarding possible breaches of fiduciary duties and other violations of law related to MyoKardias agreement to be acquired by Bristol-Myers Squibb Company. Under the terms of the agreement, MyoKardias shareholders will receive $225.00 in cash per share. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-myokardia-inc.

Cellular Biomedicine Group, Inc. (NASDAQ GS: CBMG) regarding possible breaches of fiduciary duties and other violations of law related to Cellular Biomedicines agreement to be acquired by a consortium headed by Bizuo (Tony) Liu. Under the terms of the agreement Cellular Biomedicines shareholders will receive $19.75 per share in cash. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-cellular-biomedicine-group-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:

Rigrodsky & Long, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) 654-7530info@rl-legal.com https://rl-legal.com







Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC